Arthrimel 750mg Film Coated Tablets

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Glucosamine sulfate

Διαθέσιμο από:

Phoenix Labs

Φαρμακολογική κατηγορία (ATC):

M01AX; M01AX05

INN (Διεθνής Όνομα):

Glucosamine sulfate

Δοσολογία:

750 milligram(s)

Φαρμακοτεχνική μορφή:

Film-coated tablet

Τρόπος διάθεσης:

Product not subject to medical prescription

Θεραπευτική περιοχή:

Other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

Καθεστώς αδειοδότησης:

Marketed

Ημερομηνία της άδειας:

2011-07-15

Φύλλο οδηγιών χρήσης

DISPATCH NOTE OF PRINT OUT PACKING MATERIAL
W
A
L
M
A
R
K
Design / Year:
DTP operator / Studio:
DAVID KNĚŽEK / INTERNAL
Proof numb. / Date 1. proof:
7 / 25.06.2018
Used printing material:
BO 60 G
Special printing technology:
NO
Used Colours:
1
CUT SIZE (MM):
175 X 265 MM
W
A
L
M
A
R
K
B
L
A
C
K
PHARMA CODE: 3765
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THISMEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist have told you.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more information or advice.
- If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet.
- You must talk to a doctor if you do not feel better or if you feel
worse after 1 month.
IN THIS LEAFLET:
1. What Arthrimel® is and what it is used for
2. Before you take Arthrimel®
3. How to take Arthrimel®
4. Possible side effects
5. How to store Arthrimel®
6. Further information
1. WHAT ARTHRIMEL® IS AND WHAT IT IS USED FOR
Arthrimel® belongs to a group of medicines called other
anti-inflammatory and anti-rheumatic agents, non steroids. Arthrimel®
is used for the relief of symptoms
of mild to moderate osteoarthritis of the knee that has previously
been diagnosed by your doctor.
Osteoarthritis is a type of joint degeneration that generates symptoms
such as stiffness (after sleep or long rest) and pain at motion (e.g.
when climbing the stairs
or walking along uneven surfaces).
2. BEFORE YOU TAKE ARTHRIMEL®
DO NOT TAKE ARTHRIMEL®
- If you are allergic (hypersensitive) to:
- Glucosamine or to any of the other ingredients of Arthrimel® (see
Section 6 “Further Information”)
- Shellfish, since Arthrimel® is manufactured from shellfish.
TAKE SPECIAL CARE WITH ARTHRIMEL® IF YOU
- Suffer from impaired glucose tolerance. More frequent controls of
your blood glucose levels may be necessary when starting treatment
with Arthr

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Arthrimel 750mg Film Coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 942mg glucosamine sulfate sodium
chloride equivalent to 750 mg glucosamine
sulfate.
Excipient(s) with known effect:
Each tablet contains 75.9 mg (3.3mmol) of sodium.
Lactose monohydrate 3.0 mg
Lecithin soya (E322) as part of the tablet film-coating.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablets
Off-white, oblong shaped film-coated tablet.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Arthrimel tablets are indicated for relief of symptoms in mild to
moderate osteoarthritis of the knee as diagnosed by a
doctor.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_Administration:_
Arthrimel tablets should be swallowed whole.
Tablets can be taken with or without food.
_Adults and the elderly:_
One Arthrimel tablet should be taken twice daily.
Or
Two Arthrimel tablets to be taken once daily.
Glucosamine is not indicated for the treatment of acute painful
symptoms. Relief of symptoms (especially pain relief)
may not be experienced until after several weeks of treatment and in
some cases even longer. If no relief of symptoms
is experienced after 2-3 months, continued treatment with glucosamine
should be reevaluated by your healthcare
practitioner.
Patients should seek medical advice if their symptoms deteriorate
after commencing treatment with glucosamine.
Additional information on special populations:
_Children/ adolescents:_
Safety and efficacy has not been established in children and
adolescents, therefore, Arthrimel tablets should not be used
in persons under the age of 18 years.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___